Genomics | News

SEP.12
2025

活動消息

化繁為簡－以精準化生物標誌物革新神經退化性疾病研究

Olink網路研討會

主題：化繁為簡－以精準化生物標誌物革新神經退化性疾病研究

Gain Clarity in Complexity: Transforming Neurodegeneration Research with Biomarker Precision

日期&時間：2025年9月17日 (三) 22:00

報名連結

https://www.labroots.com/en/webinar/complexity-clarity-transforming-neurodegeneration-research-biomarker-precision研討會簡介

　　神經退化性疾病仍然是醫學領域最大的挑戰之一， Olink發表了全新的生物標誌物解決方案，旨在幫助科學家以更高的精準度和信心應對神經退化性疾病研究的複雜性。

　　全新的 Olink™ Target 48 Neurodegeneration Panel 是目前首個也是唯一一個能夠在單一可擴展檢測中，同時、對定量檢測 41 種已知及新興的神經退化性疾病相關生物標誌物的工具，解鎖過往無法獲取的珍貴資訊。

研討會重點

• 來自血漿或腦脊液的神經退化性疾病生物標誌物可在單一可檢測中精確檢測和定量

• 蛋白質清單為領域專家精選，包括新興及已知生物標誌物，可深入探索疾病機制

• 生成穩健、可重複的資料，適用於跨研究、跨地點和跨時間點的縱向及橫向隊列比較

強強聯手！跨足海外基米、Illumina共創亞太基因定序與多體學創新服務

繼前次簽署合作備忘錄，基因定序領導大廠基龍米克斯生物科技股份有限公司（以下簡稱“基米”，股票代碼：4195）今（30）日宣布，與國際大廠Illumina達成策略合作夥伴關係，未來雙方將共同推動亞太地區基因定序與多體學技術的應用落地，加速產業的多元發展，並攜手搶攻全基因體定序（WGS）的龐大商機。

SEP.30
2025

IDT新知分享-Overcome challenges in cancer research with IDT’s xGen™ NGS solutions for MRD detection and methylation profiling

Next-generation sequencing (NGS) has revolutionized cancer research, enabling deeper insights into tumor biology, clonal evolution, and therapeutic resistance. However, the complexity of cancer samples—often degraded, limited in quantity, or highly heterogeneous—poses significant challenges to accurate genomic profiling. In this presentation, we showcase how xGen™ NGS solutions empower researchers to overcome these obstacles, delivering robust performance across a wide range of sample types and variant detection needs.
We highlight the integration of optimized library preparation chemistries and hybridization capture technologies workflows that enable sensitive and specific detection of low-frequency somatic variants, even in FFPE and liquid biopsy samples, which further accelerating biomarker discovery, early cancer detection and innovative MRD research.
By combining high-quality data output with streamlined workflows, xGen™ NGS solutions provide a powerful toolkit for cancer researchers seeking to push the boundaries of precision oncology.

AUG.29
2025

探索其他新聞

goldennet

化繁為簡－以精準化生物標誌物革新神經退化性疾病研究

化繁為簡－以精準化生物標誌物革新神經退化性疾病研究

其他新聞

強強聯手！跨足海外 基米、Illumina共創亞太基因定序與多體學創新服務

IDT新知分享-Overcome challenges in cancer research with IDT’s xGen™ NGS solutions for MRD detection and methylation profiling

強強聯手！跨足海外基米、Illumina共創亞太基因定序與多體學創新服務